denatonium saccharide: white powder with an extremely bitter taste [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 64772 |
| CHEMBL ID | 3185224 |
| SCHEMBL ID | 442731 |
| SCHEMBL ID | 6836990 |
| MeSH ID | M0151605 |
| Synonym |
|---|
| denatonium saccharide |
| 90823-38-4 |
| A843646 |
| benzyldiethyl[(2,6-xylylcarbamoyl)methyl]ammonium saccharide |
| benzenemethanaminium, n-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-n,n-diethyl-, salt with 1,2-benzisothiazol-3(2h)-one 1,1-dioxide (1:1) |
| unii-g2nt7smw7m |
| g2nt7smw7m , |
| dtxcid7014361 |
| dtxsid9034361 , |
| cas-90823-38-4 |
| tox21_302351 |
| NCGC00255234-01 |
| FT-0624506 |
| AKOS015897402 |
| denatonium saccharinate |
| denatonium saccharide [vandf] |
| denatonium saccharide [inci] |
| SCHEMBL442731 |
| SCHEMBL6836990 |
| CHEMBL3185224 |
| mfcd00214097 |
| denatonium saccharide, >=95% (perchloric acid titration) |
| 61724-46-7 |
| F20409 |
| 103735-41-7 |
| AS-15271 |
| Q27278654 |
| benzyl-[2-(2,6-dimethylanilino)-2-oxoethyl]-diethylazanium;1,1-dioxo-1,2-benzothiazol-3-olate |
| benzyl-[2-(2,6-dimethylanilino)-2-oxoethyl]-diethylazanium;1-oxido-1-oxo-1,2-benzothiazol-3-one |
| denatonium sacharide |
| CS-0138044 |
| SY317418 |
| D5487 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| AR protein | Homo sapiens (human) | Potency | 11.3119 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 20.1158 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 0.1793 | 0.0002 | 29.3054 | 16,493.5996 | AID743079 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 0.8008 | 0.0016 | 28.0151 | 77.1139 | AID1224843 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 35.7714 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (29.60) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||